Skip Navigation


Brain Advance Access originally published online on July 10, 2006
Brain 2006 129(9):2426-2435; doi:10.1093/brain/awl173
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/9/2426    most recent
awl173v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tabatabai, G.
Right arrow Articles by Wick, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabatabai, G.
Right arrow Articles by Wick, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-ß-dependent HIF-1{alpha}-mediated induction of CXCL12

Ghazaleh Tabatabai1, Brigitte Frank1, Robert Möhle2, Michael Weller1 and Wolfgang Wick1

1 Laboratory of Molecular Neuro-Oncology, Department of General Neurology and Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany 2 Department of Internal Medicine II (Hematology) University of Tübingen, Tübingen, Germany

Correspondence to: Wolfgang Wick, MD, Laboratory of Molecular Neuro-Oncology, Department of General Neurology and Hertie Institute for Clinical Brain Research, Hoppe-Seyler-Strasse 3, D-72076 Tübingen, Germany E-mail: wolfgang.wick{at}uni-tuebingen.de

Previously we defined a pathway of transforming growth factor beta (TGF-ß) and stromal cell-derived factor-1/CXC chemokine ligand 12 (SDF-1{alpha}/CXCL12) dependent migration of adult haematopoietic stem and progenitor cells (HPC) towards glioma cells in vitro and their homing to experimental gliomas in vivo. Hypoxia is a critical aspect of the microenvironment of gliomas and irradiation is an essential part of the standard therapy. To evaluate the therapeutic potential of HPC as vectors for a cell-based therapy of gliomas, we investigated the impact of hypoxia and irradiation on the attraction of HPC by glioma cells. Temozolomide (TMZ) treatment and hyperthermia served as controls. Supernatants of irradiated or hypoxic LNT-229 glioma cells promote HPC migration in vitro. Reporter assays reveal that the CXCL12 promoter activity is enhanced in LNT-229 cells at 24 h after irradiation at 8 Gy or after exposure to 1% oxygen for 12 h. The irradiation- and hypoxia-induced release of CXCL12 depends on hypoxia inducible factor-1 alpha (HIF-1{alpha}), but not on p53. Induction of transcriptional activity of HIF-1{alpha} by hypoxia or irradiation requires an intact TGF-ß signalling cascade. This delineates a novel stress signalling cascade in glioma cells involving TGF-ß, HIF-1{alpha} and CXCL12. Stress stimuli can be irradiation, hypoxia or TMZ, but not hyperthermia. Cerebral irradiation of nude mice at 21 days after intracerebral implantation of LNT-229 glioma induces tumour satellite formation and enhances the glioma tropism of HPC to the tumour bulk and even to these satellites in vivo. These data suggest that the use of HPC as cellular vectors in the treatment of glioblastoma may well be combined with irradiation or other anti-angiogenic therapies that induce tumour hypoxia.

Key Words: Haematopoietic progenitor cells; glioma; irradiation; non-lethal hypoxia; CXCL12; HIF-1{alpha}; TGF-ß

Abbreviations: CXCL12, CXC chemokine ligand; DAPI, 4',6'-diamidino-2-phenylindole dihydrochloride; ELISA, enzyme-linked immunosorbent assay; HIF, hypoxia-inducible factor; HPC, haematopoietic progenitor and stem cells; MMP, matrix metalloproteinase; sKitL, soluble Kit ligand; SCF, stem cell factor; SDF, stromal cell-derived factor; TGF, transforming growth factor; VEGF, vascular endothelial growth factor

Received January 25, 2006. Revised April 22, 2006. Accepted June 2, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
N. Moskovits, A. Kalinkovich, J. Bar, T. Lapidot, and M. Oren
p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts.
Cancer Res., November 15, 2006; 66(22): 10671 - 10676.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.